Mortality in Cardiogenic shock, historically speaking, is around 50%. Everyone knows that we need to get better. An amazing push in sepsis management has significantly decreased the mortality of that pathology. The last decade has seen many advances towards improving mortality but without robust results, unfortunately. Inotropes and vasopressor have failed at saving lives. There …
Continue reading Impella vs. VA-ECMO for Cardiogenic Shock s/p Myocardial Infarction